certify

Nqaba Matshazi Nqaba has been working as an investigative journalist for the last 10 years. He has written for various media outlets across the world.

September 15, 2023 377 Views
Roche was supposed to receive the FDA decision regarding the subcutaneous version of its cancer immunotherapy Tecentriq last ...
December 12, 2018 1124 Views
The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on MacroGenics’ Phase 1 trial ...
banner
Adsense